Apyx Medical
APYX
55 hedge funds and large institutions have $58.2M invested in Apyx Medical in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 7 closing their positions.
567% more call options, than puts
Call options by funds: $20K | Put options by funds: $3K
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
39% more capital invested
Capital invested by funds: $41.7M → $58.2M (+$16.5M)
10% more funds holding
Funds holding: 50 → 55 (+5)
6.55% more ownership
Funds ownership: 51.5% → 58.05% (+6.6%)
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
+$2.52M |
| 2 |
RA
Royce & Associates
New York
|
+$1.92M |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.53M |
| 4 |
TFCM
Taylor Frigon Capital Management
Scottsdale,
Arizona
|
+$938K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$552K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$1.97M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$660K |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$292K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$292K |
| 5 |
Morgan Stanley
New York
|
-$284K |
APYX Hedge Fund Activity: Q1 2023 in Review
55 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q1 2023, worth a combined $58.2M — up 39% from $41.7M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new APYX positions and 7 closed out — a net gain of 5 holders — while 12 added to existing stakes and 15 trimmed.
The largest buyer was Pura Vida Investments, adding an estimated $2.52M. The largest seller was Barclays, exiting entirely with an estimated $1.97M sold.
- 55 institutional investors held Apyx Medical (APYX) as of Q1 2023, up from 50 in Q4 2022.
- Funds reported $58.2M of Apyx Medical stock for Q1 2023, up 39% quarter-over-quarter.
- 12 funds opened new Apyx Medical positions in Q1 2023 and 7 closed out, a net change of +5 holders.
- The largest Apyx Medical buyer in Q1 2023 was Pura Vida Investments, an estimated $2.52M added.
- The largest Apyx Medical seller in Q1 2023 was Barclays, an estimated $1.97M sold.
Based on aggregated 13F filings for Q1 2023.